trans-o-flex: Covid-19 vaccines can be safely transported at 2 to 8 degrees Celsius
(PresseBox) - .
The logistics service provider specialising in the transport of pharmaceuticals attributes demands for worldwide storage and transport temperatures of minus 80 degrees to a lack of expert knowledge
trans-o-flex''s ThermoMed special network is available for the local distribution of vaccines in Germany and Austria
Active temperature control at 2 to 8 degrees, i.e. monitoring, control and documentation of compliance with the temperature range, is suitable for ruling out a possible reduction in the efficacy of Covid-19 vaccines during transport
trans-o-flex, the pharmaceutical logistics company specialising in the transport of pharmaceuticals, rejects reports according to which logistics companies would have to set up networks worldwide for the transport of Covid-19 vaccines in which the products can be stored and transported at minus 80 degrees Celsius. "Anyone who knows just a little bit about the pharmaceutical industry understands that the hastily communicated temperatures of between minus 20 and minus 80 degrees Celsius are precautions that companies must take until they have valid data on the storage life of their products also at higher temperatures," said trans-o-flex CEO Wolfgang P. Albeck. "In fact, several companies have now confirmed that Covid-19 vaccine candidates retain their efficacy even if they are treated like normal cold chain products, i.e. stored and transported at 2 to 8 degrees Celsius". Albeck cited the companies Biontech and Curevac as examples. Mainz-based Biontech, which is developing a Covid-19 vaccine together with the pharmaceutical company Pfizer, announced at a press conference that its vaccine could be stored at 2 to 8 degrees for five days. And, according to Albeck, the company intends to announce further assured results shortly. It can be assumed that the company will certify that its product has a significantly longer stability at refrigerator temperature. The T"stability over several months" at two to eight degrees Celsius.
From all this, trans-o-flex concludes that Covid-19 vaccines are also most likely to be classified as cold chain products that can be safely transported at so-called refrigerator temperature. "Thanks to our actively temperature-controlled networks, we are therefore optimally prepared for a nationwide distribution of Covid-19 vaccines," says Wolfgang P. Albeck. "The subsidiary trans-o-flex ThermoMed, which specialises in distribution in the temperature range between 2 and 8 degrees Celsius, can deliver Covid-19 vaccines, just like the influenza vaccines of recent years, to all doctors, pharmacies, hospitals and pharmaceutical wholesalers in Germany and Austria in a safe and transparently documented manner.
trans-o-flex core areas of expertise are logistics solutions for the pharmaceutical, cosmetics and consumer electronics industries and for other high-end, sensitive goods. The company has built up transport networks that convey goods at 15 to 25 degrees Celsius or at 2 to 8 degrees Celsius actively temperature-controlled and documented in accordance with EU regulations for the transport of pharmaceuticals. These EU-GDPs require the highest standards for safety and security, cleanliness, reliability and transparency, from which all trans-o-flex customers benefit. trans-o-flex operates internationally via the networks EUROTEMP (temperature-controlled logistics) and EURODIS (in 36 European countries). In contrast to conventional parcel services or forwarding agencies, trans-o-flex delivers goods in parcels as well as on pallets. trans-o-flex Express also offers numerous express and time-slot deliveries, special services such as dangerous goods transportation (without minimum quantity regulation), consignment consolidation or direct deliveries. The express shipments are complemented by warehousing, order picking and individual value-added services such as serialisation of pharmaceuticals. This means that the company covers the entire logistics chain from procurement through to fulfilment. The annual business volume of the trans-o-flex companies, which employ a total of around 2,200 people, amounted to around 495 million euros in 2019. More information is available at www.trans-o-flex.com.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
trans-o-flex core areas of expertise are logistics solutions for the pharmaceutical, cosmetics and consumer electronics industries and for other high-end, sensitive goods. The company has built up transport networks that convey goods at 15 to 25 degrees Celsius or at 2 to 8 degrees Celsius actively temperature-controlled and documented in accordance with EU regulations for the transport of pharmaceuticals. These EU-GDPs require the highest standards for safety and security, cleanliness, reliability and transparency, from which all trans-o-flex customers benefit. trans-o-flex operates internationally via the networks EUROTEMP (temperature-controlled logistics) and EURODIS (in 36 European countries). In contrast to conventional parcel services or forwarding agencies, trans-o-flex delivers goods in parcels as well as on pallets. trans-o-flex Express also offers numerous express and time-slot deliveries, special services such as dangerous goods transportation (without minimum quantity regulation), consignment consolidation or direct deliveries. The express shipments are complemented by warehousing, order picking and individual value-added services such as serialisation of pharmaceuticals. This means that the company covers the entire logistics chain from procurement through to fulfilment. The annual business volume of the trans-o-flex companies, which employ a total of around 2,200 people, amounted to around 495 million euros in 2019. More information is available at www.trans-o-flex.com.
Datum: 30.09.2020 - 01:52 Uhr
Sprache: Deutsch
News-ID 1561136
Anzahl Zeichen: 4013
contact information:
Contact person:
Town:
Weinheim
Phone:
Kategorie:
Ingredients
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 395 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"trans-o-flex: Covid-19 vaccines can be safely transported at 2 to 8 degrees Celsius
"
steht unter der journalistisch-redaktionellen Verantwortung von
trans-o-flex Express GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
